» Authors » Philippe J Eugster

Philippe J Eugster

Explore the profile of Philippe J Eugster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 126
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maurer J, Eugster P, Collins K, Vocat C, Oke J, Nicholson B, et al.
Eur Urol Open Sci . 2024 Jul; 66:12-15. PMID: 39027656
Patient Summary: This study evaluated neuropeptide Y (NPY) of the family of endogenous peptides as a new biomarker to diagnose prostate cancer. We found that NPY in a patient's blood...
2.
Maurer J, de Groot A, Martin L, Grouzmann E, Wuerzner G, Eugster P
J Pharm Biomed Anal . 2024 Mar; 243:116101. PMID: 38489957
Angiotensin peptides (ANGs) play a central role in the renin-angiotensin-aldosterone system, rendering them interesting biomarkers associated with hypertension. Precise quantification of circulating ANGs holds the potential to assess the activity...
3.
Maurer J, Grouzmann E, Eugster P
J Chromatogr B Analyt Technol Biomed Life Sci . 2023 Oct; 1229:123904. PMID: 37832388
The recent increase in peptidomimetic-based medications and the growing interest in peptide hormones has brought new attention to the quantification of peptides for diagnostic purposes. Indeed, the circulating concentrations of...
4.
Grand-Guillaume J, Mansi R, Gaonkar R, Zanger S, Fani M, Eugster P, et al.
J Transl Med . 2023 Sep; 21(1):604. PMID: 37679770
Background: Neuroblastoma (NB) and pheochromocytoma/paraganglioma (PHEO/PGL) are neuroendocrine tumors. Imaging of these neoplasms is performed by scintigraphy after injection of radiolabeled meta-iodobenzylguanidine (mIBG), a norepinephrine analog taken up by tumoral...
5.
Tripyla A, Herzig D, Reverter-Branchat G, Pavan J, Schiavon M, Eugster P, et al.
Diabetologia . 2023 Jan; 66(4):741-753. PMID: 36648553
Aims/hypothesis: Post-bariatric hypoglycaemia is an increasingly recognised complication of bariatric surgery, manifesting particularly after Roux-en-Y gastric bypass. While hyperinsulinaemia is an established pathophysiological feature, the role of counter-regulation remains unclear....
6.
Muhlethaler-Mottet A, Uccella S, Marchiori D, La Rosa S, Daraspe J, Balmas Bourloud K, et al.
Front Endocrinol (Lausanne) . 2022 Dec; 13:1027856. PMID: 36531507
Introduction: Neuroblastoma (NB) is a pediatric cancer of the developing sympathetic nervous system. It produces and releases metanephrines, which are used as biomarkers for diagnosis in plasma and urine. However,...
7.
Maurer J, Grouzmann E, Eugster P
Clin Endocrinol (Oxf) . 2022 Dec; 98(6):832-833. PMID: 36522117
No abstract available.
8.
Bourdillon N, Eugster P, Vocat C, Nguyen T, Wuerzner G, Grouzmann E, et al.
Physiol Rep . 2022 Dec; 10(23):e15515. PMID: 36461653
Neuropeptide Ys (NPYs) contribute to sympathetic-adreno stimulation: NPY1-36 potentiates the effects of catecholamines (CATs), whereas NPY3-36 inhibits CAT release. We sought to investigate whether inhibiting dipeptidyl-peptidase-4 (DPP4), cleaving NPY1-36 into...
9.
Rodriguez B, Hochstrasser A, Eugster P, Grouzmann E, Muri R, ZGraggen W
Front Neurosci . 2022 Aug; 16:968725. PMID: 35992935
Background: Brain fog is a common and highly disturbing symptom for patients with neuropathic postural tachycardia syndrome (POTS). Cognitive deficits have been measured exclusively in the upright body position and...
10.
Eugster P, Dunand M, Grund B, Ivanyuk A, Fogarasi Szabo N, Bardinet C, et al.
Clin Chim Acta . 2022 Aug; 535:19-26. PMID: 35963304
Serotonin is transformed into melatonin under the control of the light/dark cycle, representing a cornerstone of circadian rhythmicity. Serotonin also undergoes extensive metabolism to produce 5-hydroxyindoleacetic acid (5-HIAA), a biomarker...